MCH posits that deteriorating mitochondrial function triggers a series of downstream cellular changes characteristic of late-onset AD, encompassing Aβ amyloidosis, tau phosphorylation, oxidative stress, synaptic loss, and neurodegeneration (88). This evidence concerns the gene MAPT and Alzheimer disease.